Clinical trials
Active, not recruiting Graves Ophthalmopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Viridian Therapeutics, Inc. | 3 |
| Amgen | 2 |
| Minghui Pharmaceutical (Hangzhou) Ltd | 2 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| H. Lundbeck A/S | 1 |
| Tourmaline Bio, Inc., a Novartis Company | 1 |
| University Hospital, Ghent | 1 |
| Zai Lab (Shanghai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graves Ophthalmopathy | 12 |
| Graves Disease | 2 |
| Hyperthyroidism | 2 |
| Exophthalmos | 1 |
| Eye Diseases | 1 |
| Thyroid Diseases | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.